Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.66
18.11.20
€1.00
18.11.21
25.80%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
18.11.20 50%
buy
Arca Biopharma

Start price
Target price
Perf. (%)
€3.36
18.11.20
€5.00
18.11.21
5.36%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
18.11.20 50%
buy
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€2.39
18.11.20
€4.00
30.50%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
18.11.20 50%
buy
MagForce AG

Start price
Target price
Perf. (%)
€3.01
18.11.20
€4.00
18.11.21
12.29%
19.11.21

Could be worthwhile Investment >10% per year
melinda 
18.11.20 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€39.00
17.11.20
-
17.11.21
-1.74%
07.06.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Little Investments for future growth
Mori8 
17.11.20 50%
buy
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€60.55
16.11.20
€105.00
16.11.21
-10.40%
28.11.20

Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
me8 
16.11.20 50%
buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
16.11.20 50%
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.50
16.11.20
€13.00
16.11.21
-3.48%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
16.11.20 50%
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.20
16.11.20
€15.00
16.11.21
2.27%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
16.11.20 50%
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€18.10
16.11.20
€20.00
16.11.21
16.02%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
16.11.20 50%
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
16.11.20
€7.00
16.11.21
-
30.11.20

Could be very worthwhile Investment >20% year
DomRuinart 
16.11.20 50%
sell
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.20
16.11.20
-
16.11.21
-77.34%
17.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
WatchMen 
16.11.20 50%
sell
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€25.50
16.11.20
-
16.11.21
-60.78%
17.11.21

Probably not worthwhile Investment
marge 
16.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

FinanceClub_UoM 
16.11.20 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
melinda 
15.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.90
14.11.20
-
14.11.21
23.24%
27.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
14.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.30
14.11.20
-
14.11.21
-1.75%
23.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
14.11.20 50%
sell
Enzon Pharmaceuticals

Start price
Target price
Perf. (%)
€0.10
14.11.20
-
14.11.21
120.00%
14.01.21

Risky Investment
Nicheplayer
Higher risks for its business
SpringheelJack 
14.11.20 50%
sell
Horizon Pharma plc

Start price
Target price
Perf. (%)
€61.15
13.11.20
-
13.11.21
30.20%
15.07.21

Could be very worthwhile Investment >20% year
Biotechhunter 
13.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.60
13.11.20
€52.00
1.38%
14.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
13.11.20 50%
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.97
12.11.20
€50.00
12.11.21
21.49%
13.07.21

Top 10 in its market
Small cyclical dependencies
Below average Management
Partizan 
12.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.00
09.11.20
€55.00
2.66%
10.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
09.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
09.11.20 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€24.26
09.11.20
-
09.11.21
21.35%
14.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Judge 
09.11.20 50%
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.41
09.11.20
€40.00
09.11.21
18.27%
02.11.21

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stipica 
09.11.20 50%